Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2002JAMA

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

Patrick W. SerruysPatrick W. SerruysInterventional / Structural Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Patrick W. Serruys (2002) studied this question.

synapsesocial.com/papers/6a10752ae1a472cb5efcf13ahttps://doi.org/10.1001/jama.287.24.3215
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy1999 · 326 citations
  2. 2Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.1994 · 46 citations
  3. 3Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention2002 · 248 citations
  4. 4The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease2001 · 30 citations